Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Lantheus Holdings (NQ: LNTH )

87.50 -0.81 (-0.92%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 8, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Lantheus Holdings

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Market Rally Finishes Strong; Regional Banks, Fed Rate Hike, Jobs Report, Apple In Focus: Weekly Review
The major indexes retreated for most of the week on banking fears, 
Via Investor's Business Daily
Zillow, Shopify, Datadog And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded lower, with the Dow Jones falling around 400 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Lantheus Holdings Earnings Perspective: Return On Capital Employed
Via Benzinga
Why Shares of Lantheus Holdings Rose This Week
The company's fourth-quarter and full-year earnings were a pleasant surprise. 
Via The Motley Fool
Why Synaptics Shares Are Trading Lower By 17%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers Qurate Retail, Inc. (NASDAQ: QRTEB) shares jumped 89.3% to $7.44. 
Via Benzinga
Why Shares of Lantheus Holdings Are Up Thursday
The company reported a record quarter for revenue. 
Via The Motley Fool
Lantheus Reports First Quarter 2023 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus and POINT Biopharma Announce FDA Grants Fast Track Designation for ¹⁷⁷Lu-PNT2002 for the Treatment of Metastatic Castration Resistant Prostate Cancer
From Lantheus Holdings, Inc.; POINT Biopharma Global Inc.
Via GlobeNewswire
Lantheus to Host First Quarter 2023 Earnings Conference Call and Webcast on May 4, 2023, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Two Key Executive Promotions
Paul Blanchfield promoted to President; Dan Niedzwiecki promoted to Chief Administrative Officer 
From Lantheus Holdings, Inc.
Via GlobeNewswire
Are These Medical Device Makers Getting Ready To Rally?
Current trends and changing demographics are behind growth of medical technology companies. An aging population and a shift to in-home care are among factors. 
Via MarketBeat
Benzinga's Top Ratings Upgrades, Downgrades For March 8, 2023
Via Benzinga
Why Domino's Pizza Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Gainers 
Via Benzinga
Comfort Systems, Gannett, CommScope And Other Big Stocks Moving Higher On Thursday
U.S. stocks traded slightly lower, with the Dow Jones dropping around 30 points on Thursday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Nasdaq Jumps 100 Points; US GDP Rises 2.7% In Q4
U.S. stocks traded higher this morning, with the Dow Jones gaining over 100 points on Thursday. Following the market opening Thursday, the Dow traded up 0.35% to 33,162.00 while the NASDAQ rose 0.91%... 
Via Benzinga
Lantheus Shares Jump On Upbeat 2023 Guidance, Q4 Earnings Surpass Expectations
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Lantheus Reports Fourth Quarter and Full Year 2022 Financial Results
From Lantheus Holdings, Inc.
Via GlobeNewswire
Earnings Scheduled For February 23, 2023
Companies Reporting Before The Bell • ChipMOS TECHNOLOGIES (NASDAQ:IMOS) is likely to report earnings for its fourth quarter. 
Via Benzinga
Lantheus Presents Data Reinforcing Real-World Clinical Utility of Piflufolastat F 18 PET Scanning in Men with Recurrent Prostate Cancer and Low PSA Levels
Data presented at the American Society of Clinical Oncology Genitourinary Cancers Symposium Demonstrate Potential Benefits of Piflufolastat F 18 Decision Making on Treatment Plans 
From Lantheus Holdings, Inc.
Via GlobeNewswire
Meet A Cannabis Executive Who Knows How To Reinvent The Business: Gary Santo Of TILT Holdings
After the overwhelming success of last year's Benzinga Cannabis Capital Conference, the team is returning to Florida April 11-12, 2023 with awesome events simultan 
Via Benzinga
Lantheus to Host Fourth Quarter and Full Year 2022 Earnings Conference Call and Webcast on February 23, 2023, at 8:00 a.m. Eastern Time
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Present Piflufolastat F 18 Data at the 2023 American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Acquisition of Cerveau Technologies, Inc., Expanding Imaging Pipeline into Alzheimer’s Disease
MK-6240 is an F 18-labeled PET imaging agent that targets Tau tangles in Alzheimer’s Disease 
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus to Present at the J.P. Morgan 2023 Healthcare Conference
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Announces Closing of Strategic Collaboration and Exclusive License Agreements for the Commercialization of PNT2002 & PNT2003 with POINT Biopharma
From Lantheus Holdings, Inc.
Via GlobeNewswire
Cramer's Take On This Stock Up 48% Year-To-Date: 'I Would Not Want To Come In At This Level'
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Royal Caribbean Cruises Ltd (NYSE: RCL) is an "excellent" company. 
Via Benzinga
Lantheus Grants Rights for the Use of its Microbubbles to SonoThera for its Ultrasound-Guided Nonviral Gene Therapy Platform
From Lantheus Holdings, Inc.
Via GlobeNewswire
Lantheus Holdings, Inc. Announces Pricing of Offering of $500 Million Convertible Senior Notes due 2027
From Lantheus Holdings, Inc.
Via GlobeNewswire
Why Iovance Biotherapeutics Shares Are Trading Higher By Around 19%? Here Are 40 Stocks Moving In Monday's Mid-Day Session
Gainers Winc, Inc. (NYSE: WBEV) rose 88.5% to $0.3901 after dropping over 23% on Friday. Winc, last month, posted a Q3 loss of $0.33 per share. 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.